Published in Eur Radiol on January 01, 1997
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol (2004) 1.56
Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol (2008) 1.35
Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol (2009) 1.08
Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging (2012) 1.08
CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree. Br J Radiol (2012) 1.02
Non-invasive detection of biliary leaks using Gd-EOB-DTPA-enhanced MR cholangiography: comparison with T2-weighted MR cholangiography. Eur Radiol (2013) 0.96
Spontaneous Biliary Perforations: An Uncommon yet Important Entity in Children. J Clin Diagn Res (2013) 0.93
Safety of MR liver specific contrast media. Eur Radiol (2004) 0.90
Correlation of liver parenchymal gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid enhancement and liver function in humans with hepatocellular carcinoma. Oncol Lett (2012) 0.84
Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis. J Magn Reson Imaging (2012) 0.82
Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent. Biologics (2010) 0.80
MR cholangiopancreatography findings in children with spontaneous bile duct perforation. Pediatr Radiol (2010) 0.79
Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensity. BMC Cancer (2015) 0.77
Biliary peritonitis after radiofrequency ablation diagnosed by gadoxetic acid-enhanced MR imaging. Korean J Radiol (2013) 0.75
Adult-to-adult right lobe living donor liver transplantation: comparison of endoscopic retrograde cholangiography with standard T2-weighted magnetic resonance cholangiography for evaluation of donor biliary anatomy. World J Gastroenterol (2006) 0.75
Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective! Int J Hepatol (2013) 0.75
The T2-shortening effect of gadolinium and the optimal conditions for maximizing the CNR for evaluating the biliary system: a phantom study. Korean J Radiol (2011) 0.75
Diagnostic value of Gd-EOB-DTPA-enhanced MR cholangiography in non-invasive detection of postoperative bile leakage. Br J Radiol (2017) 0.75
Quantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: differences between hepatocellular carcinoma, hepatic focal nodular hyperplasia and cavernous hemangioma. Oncotarget (2017) 0.75
Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. Arthritis Rheum (1999) 3.42
Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol (1984) 2.95
Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology (1995) 2.38
Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR (1984) 2.30
Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology (1993) 2.29
Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis (2000) 1.85
Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology (1992) 1.65
Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis (2002) 1.63
Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology (1994) 1.56
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients. Radiology (1992) 1.53
Occlusive myocardial infarction: investigation of bis-gadolinium mesoporphyrins-enhanced T1-weighted MR imaging in a cat model. Radiology (2001) 1.47
Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children with juvenile arthritides. J Rheumatol (1998) 1.46
Central venous port catheters: evaluation of patients' satisfaction with implantation under local anesthesia. J Vasc Access (2009) 1.45
Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther (1999) 1.44
Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy. Prostate Cancer Prostatic Dis (2012) 1.42
Early sacroiliitis in patients with spondyloarthropathy: evaluation with dynamic gadolinium-enhanced MR imaging. Radiology (1995) 1.40
Gd-EOB-DTPA and Yb-EOB-DTPA: two prototypic contrast media for CT detection of liver lesions in dogs. Radiology (1997) 1.40
Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. AJR Am J Roentgenol (2001) 1.38
[Indications for liver biopsy in liver tumors]. Dtsch Med Wochenschr (2000) 1.38
Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: imaging findings and diagnosis using MR imaging. Eur Radiol (2000) 1.34
Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology (1999) 1.31
Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum (2003) 1.29
Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol (2000) 1.27
Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging (1995) 1.25
Static magnetic resonance imaging of the pelvic floor muscle morphology in women with stress urinary incontinence and pelvic prolapse. Neurourol Urodyn (1998) 1.24
Rheumatoid arthritis: evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA. Radiology (1990) 1.23
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study. Radiology (2000) 1.21
fMRI shows multiple somatotopic digit representations in human primary somatosensory cortex. Neuroreport (2000) 1.19
Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging (2001) 1.18
Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent. MAGMA (2001) 1.18
Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol (2001) 1.16
Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology (1994) 1.15
Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol (2010) 1.15
Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Pre-clinical profile of SH U555A. Acta Radiol (1997) 1.14
Prospective 7 year follow up imaging study comparing radiography, ultrasonography, and magnetic resonance imaging in rheumatoid arthritis finger joints. Ann Rheum Dis (2005) 1.13
Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents. J Magn Reson Imaging (2000) 1.13
Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging. Radiology (1991) 1.11
In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest Radiol (1991) 1.10
Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut (1996) 1.10
Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR Am J Roentgenol (1984) 1.08
Detection and characterisation of liver metastases. Eur Radiol (2004) 1.08
MR imaging of septic sacroiliitis. Skeletal Radiol (2000) 1.07
Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging. Magn Reson Imaging (2000) 1.05
Multislice CT coronary angiography: evaluation of an automatic vessel detection tool. Rofo (2004) 1.04
CT-guided intraarticular corticosteroid injection into the sacroiliac joints in patients with spondyloarthropathy: indication and follow-up with contrast-enhanced MRI. J Comput Assist Tomogr (1996) 1.04
Localisation of neuroendocrine tumours of the upper gastrointestinal tract. Gut (1994) 1.04
Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet (1984) 1.03
Sclerosing mesenteritis as a rare cause of upper abdominal pain and digestive disorders. Acta Radiol (2008) 1.02
Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondyloarthritis. Ann Rheum Dis (2007) 1.01
Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging. Bioconjug Chem (2001) 1.01
fMRI assessment of somatotopy in human Brodmann area 3b by electrical finger stimulation. Neuroreport (1998) 1.01
Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits. Radiology (2000) 1.01
Multislice CT coronary angiography: effect of sublingual nitroglycerine on the diameter of coronary arteries. Rofo (2006) 1.00
Diffuse idiopathic skeletal hyperostosis (DISH): relation to vertebral fractures and bone density. Osteoporos Int (2010) 1.00
B-mode enhancement at phase-inversion US with air-based microbubble contrast agent: initial experience in humans. Radiology (2000) 1.00
Results of a prospective multicenter study for evaluation of the diagnostic quality of an open whole-body low-field MRI unit. A comparison with high-field MRI measured by the applicable gold standard. Eur J Radiol (1999) 1.00
Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. Radiology (2001) 0.99
Indications, imaging technique, and reading of cardiac computed tomography: survey of clinical practice. Eur Radiol (2011) 0.99
Adrenal myelolipoma: clinical, radiologic, and histologic features. Urology (1987) 0.99
A new concept for melatonin deficit: on pineal calcification and melatonin excretion. Neuropsychopharmacology (1999) 0.98
Ovarian artery embolization in patients with collateral supply to symptomatic uterine leiomyomata. Cardiovasc Intervent Radiol (2010) 0.97
New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits. J Magn Reson Imaging (2000) 0.96
Use of contrast enhanced magnetic resonance imaging to detect spinal inflammation in patients with spondyloarthritides. Clin Exp Rheumatol (2002) 0.96
MR-guided interstitial laser-induced thermotherapy of hepatic metastasis combined with arterial blood flow reduction: technique and first clinical results in an open MR system. J Magn Reson Imaging (2001) 0.96
Pre-clinical evaluation of gadobutrol: a new, neutral, extracellular contrast agent for magnetic resonance imaging. Eur J Radiol (1995) 0.96
Magnetic resonance myelography (MRM) as a spinal examination technique. Acta Neurochir (Wien) (1997) 0.95
Outcome prediction in patients after cardiac arrest: a simplified method for determination of gray-white matter ratio in cranial computed tomography. Clin Neuroradiol (2014) 0.95
Early postoperative ultrasound of kidney transplants: evaluation of contrast medium dynamics using time-intensity curves. Rofo (2004) 0.93
Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques: postmortem analysis of accuracy, inter-observer agreement, and pitfalls. Invest Radiol (2002) 0.93
Results of the safety and efficacy of iobitridol in more than 61,000 patients. Eur Radiol (2002) 0.92
Minimally invasive catheter implantation for regional chemotherapy of the liver: a new percutaneous transsubclavian approach. Cardiovasc Intervent Radiol (1997) 0.92
Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med (2005) 0.91
Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol (2013) 0.91
MR-guided laser ablation of osteoid osteoma in an open high-field system (1.0 T). Cardiovasc Intervent Radiol (2008) 0.91
CT coronary angiography using 16 and 64 simultaneous detector rows: intraindividual comparison. Rofo (2007) 0.90
Liver volume measurement: reason of the difference between in vivo CT-volumetry and intraoperative ex vivo determination and how to cope it. Eur J Med Res (2010) 0.90
Passive tracking of catheters and guidewires by contrast-enhanced MR fluoroscopy. Magn Reson Med (2001) 0.90
[Sacroiliitis in children with spondyloarthropathy: therapeutic effect of CT-Guided intra-articular corticosteroid injection]. Rofo (2003) 0.90
[MRI of the knee joint of young soccer players. Are there early changes of the internal structures of the knee due to competitive sports?]. Rofo (1994) 0.89
Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR Am J Roentgenol (1984) 0.89
Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography. MAGMA (1999) 0.89
Magnetic resonance angiography with gadomer-17. An animal study original investigation. Invest Radiol (1998) 0.89